Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Selina M. Luger, MD

Selina M. Luger, MD Physician

Director, Leukemia Program Professor of Medicine at the Hospital of the University of Pennsylvania

Languages spoken:

  • French

Dr. Luger is employed by Penn Medicine.

About Dr. Selina M. Luger

Recognized by America's Top Doctors, 2013-14

Recognized by Best Doctors in America 2009-2010, 2011-2012, 2013-2014

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Hematology
  • Medical Oncology

Programs & Centers:

Board Certification:

  • Hematology, 1994

Clinical Expertise:

  • Leukemia
  • Stem Cell Transplant

Description of Clinical Expertise

hematologic malignancies, leukemia, AML, ALL, CML, myelodysplastic syndrome, MDS, myeloproliferative disorders, stem cell transplantation, bone marrow transplant

Practice Locations and Appointments

  • Abramson Cancer Center

    Perelman Center for Advanced Medicine West Pavilion, 4th Floor 3400 Civic Center Boulevard Philadelphia, PA 19104 800-789-7366 (PENN)

    A facility of the Hospital of the University of Pennsylvania

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School:
Residency: Presbyterian University Hospital
Fellowship: Hospital of the University of Pennsylvania


American Society of Clinical Oncology, National American Society of Hematology, National American Society of Hematology, National American Society of Hematology, National American Society of Hematology, National American Society of Hematology, National Center for International Blood and Marrow Transplant Research (CIBMTR), International Eastern Cooperative Oncology Group, National Leukemia and Lymphoma Society, Eastern Pennsylvania Chapter , Local New Jersey Commission for Cancer Research , Local Royal College of Physicians and Surgeons of Canada, National

Hospital Affiliation

Dr. Luger is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Leukemia, myelodysplastic syndrome, myeloproliferative disorders

Selected Publications:

Tasian SK1, Hurtz C2, Wertheim GB3, Bailey NG4, Lim MS4, Harvey RC5, Chen IM5, Willman CL5, Astles R2, Zebrowski A2, Reshmi SC6, Li MM7, Frey NV2, Luger SM2, Carroll M2: High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL. Leukemia. 31 (4): 981-984,2017.

Stock W1,2, Diouf B3,4, Crews KR3,4, Pei D3,5, Cheng C3,5, Laumann K2,6, Mandrekar SJ2,6, Luger S7, Advani A8, Stone RM2, Larson RA1,2: An Inherited Genetic Variant in CEP72 Promoter Predisposes to Vincristine-Induced Peripheral Neuropathy in Adults With Acute Lymphoblastic Leukemia. Clin Pharmacol Ther. 101 (3): 391-395,2017.

Wide Variations in Blood Product Transfusion Practices among Providers Who Care for Patients with Acute Leukemia in the United States Transfusion 57 (2): 289-295,2017.

Roberts KG1, Gu Z1, Payne-Turner D1, McCastlain K1, Harvey RC1, Chen IM1, Pei D1, Iacobucci I1, Valentine M1, Pounds SB1, Shi L1, Li Y1, Zhang J1, Cheng C1, Rambaldi A1, Tosi M1, Spinelli O1, Radich JP1, Minden MD1, Rowe JM1, Luger S1, Litzow MR1, Tallman MS1, Wiernik PH1, Bhatia R1, Aldoss I1, Kohlschmidt J1, Mrózek K1, Marcucci G1, Bloomfield CD1, Stock W1, Kornblau S1, Kantarjian HM1, Konopleva M1, Paietta E1, Willman CL1: High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults. J Clin Oncol. 35 (4): 394-401,2017.

Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M: Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biol Blood Marrow Transplant. 22 (2): 248-57,2016.

Zhang J1, McCastlain K2, Yoshihara H2, Xu B1, Chang Y2, Churchman ML2, Wu G1, Li Y1, Wei L1,2, Iacobucci I2, Liu Y1, Qu C1, Wen J1, Edmonson M1, Payne-Turner D2, Kaufmann KB3, Takayanagi SI3,4, Wienholds E3, Waanders E2,5, Ntziachristos P6, Bakogianni S6, Wang J6, Aifantis I6,7, Roberts KG2, Ma J2, Song G2, Easton J1, Mulder HL1, Chen X1, Newman S1, Ma X1, Rusch M1, Gupta P1, Boggs K1, Vadodaria B1, Dalton J2, Liu Y2, Valentine ML8, Ding L9, Lu C9, Fulton RS9, Fulton L9, Tabib Y9, Ochoa K9, Devidas M10: Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat Genet. 48 (12): 1481-1489,2016.

Ganzel C, Manola J, Douer D, Rowe JM, Fernandez HF, Paietta EM, Litzow MR, Lee JW, Luger SM, Lazarus HM, Cripe LD, Wiernik PH: Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008. J Clin Oncol. 34 (29): 3544-3553,2016.

Kumar AJ, Gimotty PA, Gelfand J, Buck G, Rowe JM, Goldstone AH, Fielding A, Marks DI, Litzow M, Paietta E, Lazarus HM, Tallman MS, Luger SM: Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Transplant: An Analysis from ECOG 2993/MRC UK ALLXII. Am J Hematol. : 2016.

Li S1, Garrett-Bakelman FE2, Chung SS3, Sanders MA4, Hricik T3, Rapaport F3, Patel J3, Dillon R5, Vijay P6, Brown AL7,8,9, Perl AE10, Cannon J10, Bullinger L11, Luger S10, Becker M12, Lewis ID7,9,13, To LB9,13, Delwel R4, Löwenberg B4, Döhner H11, Döhner K11, Guzman ML2, Hassane DC2, Roboz GJ2, Grimwade D5, Valk PJ4, D'Andrea RJ7,8,9, Carroll M10, Park CY14,15, Neuberg D16, Levine R3, Melnick AM2: Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia. Nat Med. 22 (7): 792-9,2016.

Luskin MR, Carroll M, Lieberman D, Morrissette JJ, Zhao J, Crisalli L, Roth DB, Luger SM, Porter DL: Clinical Utility of Next Generation Sequencing for Oncogenic Mutations in AML Patients Undergoing Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. : 2016.

Academic Contact Info

Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-101
34th and Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 614-1847
Patient appointments: 800-789-7366 (PENN)

Related Links